Anti-angiogenesis Chemotherapy Agents: the Role of Anti-angiogenesis at Cancer Treatment - Duygu Citak - Libros - LAP LAMBERT Academic Publishing - 9783845420097 - 1 de septiembre de 2011
En caso de que portada y título no coincidan, el título será el correcto

Anti-angiogenesis Chemotherapy Agents: the Role of Anti-angiogenesis at Cancer Treatment

Duygu Citak

Los regalos de Navidad se podrán canjear hasta el 31 de enero
Añadir a tu lista de deseos de iMusic

Anti-angiogenesis Chemotherapy Agents: the Role of Anti-angiogenesis at Cancer Treatment

Angiogenesis can be explained as the growth of new blood vessels from pre-existing vasculature. It has an important and vital role in growth and development, as well as in wound healing. Anti-angiogenic substances suppress the growth of new blood vessels so prevent nutrients and oxygen needed for the growing of tumor cells. It is proposed that tumor angiogenesis could serve as a potential target for anticancer therapy. Combretastatin (CA-4) is an anti-angiogenesis agent that inhibits the tubulin polymerization. CA-4 exhibits anti-tumor effects through the well-organized therapeutic mechanism of tumor blood supply disabling. By affecting selectively and blocking tumor vasculature, CA-4 reduces the blood supply needed for tumor growth and survival. As a result of oxygen poverty and build-up of tumor metabolic by-products causes the death of the cancer cells within the central core of the tumor. In this thesis, covalent modification of CA-4 has been investigated. Variety of CA-4 analogs which involved blocking the free alcohol group has been synthesized.

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 1 de septiembre de 2011
ISBN13 9783845420097
Editores LAP LAMBERT Academic Publishing
Páginas 80
Dimensiones 150 × 5 × 226 mm   ·   127 g
Lengua English